Everand Logo

Welcome to Everand!

  • STAT

    Opinion: It isn’t crazy to conduct an Ebola clinical trial in a war zone — it’s necessary

    The only way to evaluate possible treatments for #Ebola is to test them in a clinical trial, even though the current outbreak is spreading in what's akin to a war…
    by Jeremy Farrar Dec 04, 2018 3 minutes
    Health workers move a patient to a hospital in Butembo, Democratic Republic of the Congo, after he was cleared of having Ebola.

    The term “randomized controlled trial” conjures up images of sterile, high-tech labs with closely monitored patients hooked up to numerous machines. That’s a far cry from the reality of a brave and groundbreaking trial that began last week in the Democratic Republic of the Congo to investigate lifesaving treatments for Ebola.

    The DRC is in the midst of one of the worst Ebola outbreaks it has faced. With at least 260 people killed so far, it is

    You’re reading a preview, subscribe to read more.

    More from STAT

    STAT2 min read
    STAT+: Pharmalittle: We’re Reading About A J&J Cough Syrup, A Pfizer And Moderna Patent Suit, And More
    A Johnson & Johnson children’s cough syrup found to contain unsafe levels of a toxic industrial solvent was sold in six African countries.
    STAT1 min read
    USDA Faulted For Disclosing Scant Information About Outbreaks Of H5N1 Avian Flu In Cattle
    With 28 herds in eight states infected with H5N1 bird flu, scientists are calling on the U.S. to release more data to help them assess the risk.
    STAT2 min read
    STAT+: Pharmalittle: We’re Reading About Lilly’s Zepbound For Sleep Apnea, The FDA Budget, And More
    Eli Lilly reported positive results for Zepbound in obstructive sleep apnea, giving the medication a new edge in the highly competitive obesity market.

    Related Books & Audiobooks